Here, we provide the first evidence of improved healthspan and age-related survival with a therapeutic mAb by demonstrating that treatment with an IGF-1R antagonist in older mice significantly and preferentially improves several indices of healthspan, reduced death from neoplastic disease, and increased mean and median lifespan in females
Clinical trials demonstrate substantial body weight loss through reduced caloric intake, not increased energy expenditure
This patient said that she felt like a new person and has never felt better. Chronic fatigue was one of her primary symptoms, and she had complete resolution of fatigue within weeks
Hernndez-Saavedra, D., Moody, L., Xu, G
This injectable medication can be a valuable tool for those struggling with weight loss
The best peptides to stack with Tirzepatide depend on your specific goals during your weight loss journey